Tritoqualine
|  | |
| Systematic (IUPAC) name | |
|---|---|
| 7-amino-4,5,6-triethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-isobenzofuran-1-one | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names | 
| Identifiers | |
| CAS Number | 14504-73-5 | 
| ATC code | R06AX21 | 
| PubChem | CID 72145 | 
| ChemSpider | 65119 | 
| UNII | F4MW5166YH  | 
| Chemical data | |
| Formula | C26H32N2O8 | 
| Molar mass | 500.54 g/mol | 
| 
 | |
Tritoqualine, also known as hypostamine, is an inhibitor of the enzyme histidine decarboxylase and therefore an atypical antihistamine, used for the treatment of urticaria and allergic rhinitis[1] with no known adverse effects.
References
- ↑ Randomized, placebo controlled study of tritoqualine (hypostamine*) in the treatment of perennial allergic rhinitis. A. Pradalier, V. Hentschel, S. Prouzeau, D. Legallais, G. Lefrançois. Revue Française d’Allergologie et d’Immunologie Clinique 43:175-179 (2003)
| 
 | ||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, December 08, 2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.